Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.40 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.40 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.40 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 2/20 | 0.37 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12270707 | 0.83 | DPP4 (0.48) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL19410810 | 0.79 | KDM4E (0.46) | KDM4EADRA2ALMNAALDH1A1ORAI1 | |
| SCHEMBL3463761 | 0.78 | ORAI1 (0.48) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL18257694 | 0.74 | THRB (0.53) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL9870121 | 0.74 | ADRA2A (0.50) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL16888402 | 0.74 | THRB (0.53) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL12262583 | 0.74 | THRB (0.53) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL3627338 | 0.74 | THRB (0.53) | KDM4EADRA2AADRA2CLMNAHIF1A | |
| SCHEMBL7461066 | 0.73 | ORAI1 (0.52) | KDM4ELMNAALDH1A1ORAI1ORAI2 | |
| Hydrochloric Acid SCHEMBL22774703 | 0.72 | ALDH1A1 (0.52) | KDM4EADRA2AADRA2CLMNAHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090082561-A1 | Methods For The Preparation Of Alkyl Diaryl Borinates And Complexed Diarylboronic Acids | THE PENNSYLVANIA STATE RESEARCH FOUNDATION | 2009-03-26 | — | — | US | claimed |
| US-20050080048-A1 | Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids | PENN STATE RESEARCH FOUNDATION, THE | 2005-04-14 | — | — | US | claimed |
| US-7405304-B2 | Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids | THE PENN STATE RESEARCH FOUNDATION (US) | 2008-07-29 | — | — | US | disclosed |
| EP-1339725-B1 | DNA METHYL TRANSFERASE INHIBITORS | PENN STATE RES FOUND (US) | 2006-11-22 | — | — | EP | disclosed |
| US-20050227933-A1 | Treatment of bacterial induced diseases using DNA methyl transferase inhibitors | BENKOVIC STEPHEN J | 2005-10-13 | — | — | US | disclosed |
| US-20050080048-A1 | Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids | PENN STATE RESEARCH FOUNDATION, THE | 2005-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090082561-A1 | Methods For The Preparation Of Alkyl Diaryl Borinates And Complexed Diarylboronic Acids | BCL6B, BLVRB, SSB | KDM4E 2810/4885ADRA2A 2317/4885ADRA2C 2195/4885 |
| US-20050080048-A1 | Methods for the preparation of alkyl diaryl borinates and complexed diarylboronic acids | BCL6B, BLVRB, SSB | KDM4E 2810/4885ADRA2A 2317/4885ADRA2C 2195/4885 |
| US-20050227933-A1 | Treatment of bacterial induced diseases using DNA methyl transferase inhibitors | DNMT1, TPMT, GNMT | KDM4E 698/4885ADRA2A 4685/4885ADRA2C 4754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.